Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Stroke 1Precancerous Conditions 1Neoplasms 1Melanoma 1Liver Cirrhosis 1Ischemic Attack, Transient 1Healthy Participants 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Atherosclerosis 1Adenomatous Polyps 1

Interventions

Leucovorin 38Fluorouracil 36Oxaliplatin 34Bevacizumab 34Irinotecan 32Cetuximab 23Capecitabine 18Panitumumab 14IFL protocol 7Folfox protocol 6Celecoxib 6Radiotherapy 5Nivolumab 5Magnetic Resonance Spectroscopy 5Immunohistochemistry 5Gene Expression Profiling 5regorafenib 4pembrolizumab 4dehydroftorafur 4Ramucirumab 4Fluorodeoxyglucose F18 4Floxuridine 4aflibercept 3Surgical Procedures, Operative 3Sorafenib 3Radiosurgery 3Ipilimumab 3Gemcitabine 3Fentanyl 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Colonic Neoplasms × Rosuvastatin Calcium × Clear all
NCT01011478 2023-08-16

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

NSABP Foundation Inc

Phase 3 Terminated
406 enrolled 14 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡